> ## Content Index
> Fetch the complete content index at: https://www.coios.me/llms.txt
> Use this file to discover other available public pages before exploring further.

# Excess mortality after mental disorder diagnosis varies by care setting and timing
- URL: https://www.coios.me/excess-mortality-after-mental-disorder-diagnosis-varies-by/
- Published: 2026-11-15T11:47:09.000Z
- Updated: 2026-11-15T12:12:12.000Z
- Description: In Finland, excess mortality after depressive, anxiety or stress-related diagnoses without specialist care showed little evidence beyond two years.
- Author: Daniel Ryan
- Tags: Health today, Mental health, Finland, #preprint, #refines, #item, #source-2026-11, #score-85

This nationwide cohort followed 5,526,599 Finnish residents aged 5-95 without recorded mental disorders over 63 million person-years, 2011-2023\. Of these, 26.5% were diagnosed, with an overall adjusted mortality rate ratio of 2.65 (95% CI 2.53-2.77) versus undiagnosed residents. Among those aged 5-64, 46.1% had depressive, anxiety or stress-related disorders without substance use disorder or specialist care. At two years, their mortality rate ratios ranged from 0.88 to 1.12, with no clear excess. Excess persisted in specialist care, especially with substance use disorder, and in psychotic disorders and older adults with depression. This group excluded anyone later given specialist care or a substance use diagnosis, so membership relied on events after diagnosis.

*Why it is interesting: Much evidence on excess mortality in mental disorders comes from specialist psychiatric populations. Here, 46.1% of diagnosed people aged 5-64 formed a subgroup without substance use disorder or specialist care whose excess faded.*

Source

[medRxiv, 11 November 2026](https://doi.org/10.64898/2026.09.02.26362001?ref=coios.me)

Paper

Excess mortality after mental disorder diagnosis within and outside specialist psychiatric care: nationwide cohort study

Authors

Suokas K, Gutvilig M, Komulainen K, Alho J, McGrath JJ, Pirkola S et al.

DOI

10.64898/2026.09.02.26362001

Type

Preprint

Design

Nationwide register-based cohort, 5,526,599 Finnish residents aged 5-95, 2011-2023, 63 million person-years, mortality rate ratios by care setting and time since diagnosis

Verdict

Refines prior evidence

Driver

[Mental health](https://www.coios.me/d-mental-health/)

Abstract — the authors' own words, CC BY

Background

People with mental disorders have shortened life expectancy, but much evidence on excess mortality comes from specialist psychiatric populations. We examined variation across the broader diagnosed population by clinical context and time since diagnosis. Methods

We followed 5,526,599 Finnish residents aged 5–95 years without recorded mental disorders at entry from 2011 to 2023 (63 million person-years). ICD-11-grouped diagnoses and mortality rate ratios (MRRs) were assessed by time since diagnosis, psychiatric care setting, substance use disorder (SUD) status, age, and cause of death. Results

During follow-up, 1,463,064 individuals (26.5%) received a diagnosis; the overall adjusted MRR was 2.65 (95% CI 2.53–2.77). However, among diagnosed individuals aged 5–64 years, 46.1% belonged to a subgroup with rapidly declining excess mortality and little evidence of excess beyond two years. This subgroup had depressive, anxiety or fear-related, or stress-related disorders without diagnosed SUD or specialist psychiatric care during follow-up. At two years, MRRs ranged from 0.88 (95% CI 0.73–1.06) to 1.04 (0.88–1.22) in men and 0.92 (0.79–1.07) to 1.12 (0.96–1.31) in women. Excess mortality persisted in specialist care and was particularly high with SUD. It also persisted without SUD or specialist care in schizophrenia and other primary psychotic disorders and older adults with depression. Conclusions

Excess mortality after mental disorder diagnosis may be transient in large parts of the diagnosed population while remaining persistent in others with the same diagnosis. Recognizing these differences is important for interpreting mortality estimates and communicating prognosis across health care.